İstanbul Medipol University
Istanbul, Beykoz, 34810, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07022106
This study is investigating the effects of myofascial release technique & kinesiotape in managing dysmenorrhea
Interested in participating?
Request Info18 year–30 year
Female
Interventional
Not applicable
Istanbul, Beykoz, 34810, Turkey (Türkiye)
Location status: Recruiting
Dysmenorrhea is a common gynecological disorder characterized by painful menstruation manifested by severe cramps in the lower abdomen. Recent epidemiological studies indicate a global prevalence of 50-90% among women (10-20% with severe symptoms); in Türkiye, studies show a prevalence of 75-85%.Dysmenorrhea is divided into two types: primary dysmenorrhea (PD) and secondary dysmenorrhea. PD is painful menstruation without any underlying pathological condition. The main goal of dysmenorrhea treatment is to significantly improve the patient's well-being and quality of life (QoL) by effectively relieving pain and relieving symptoms by targeting physiological mechanisms. There are various physiotherapy methods that can be used to reduce this pain, such as transcutaneous electrical nerve stimulation (TENS), cryotherapy, myofascial release therapy (MRT), and kinesiology taping (KT).
This single-blind randomized controlled trial will investigate the acute therapeutic effects of Myofascial Release Technique (MRT) versus Kinesio Taping (KT) in 46 females aged 18-30 years with PD. Participants will be randomised into Group 1 (MRT; n = 23) or Group 2 (KT; n = 23), receiving a single intervention session during their most painful menstrual day
All participants will be asked to fill out 3 forms, namely a sociodemographic questionnaire covering age, height, BMI, age at menarche and duration of menstruation, a Visual Analog Scale (VAS) to assess pain level and a Patient Reported Outcomes Measurement System (PROMIS-29 Profile v2.0) to measure quality of life (QoL) at 3 time points (pre-intervention, 8 hours after intervention ,and 3-5 weeks post intervention (at the first menstrual cycle after intervention).
Statistical analyses will be conducted by using SPSS 27.0 (IBM Corp.), with a priori power analysis confirming 95% power (α = 0.05; G*Power v3.1.9.7). Data normality will be verified via the Shapiro-Wilk test. Independent Samples t-tests will compare interventional effects between groups, while one-way ANOVA (with LSD post-hoc tests) will analyze multi-point QoL changes. Paired Samples t-tests will evaluate within-group temporal changes (pre vs. post-intervention).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Myofascial Release Therapy (MRT) involves hands-on palpation to detect fascial restrictions, followed by 60-90 seconds of sustained pressure to release tension. In the supine position, the target areas include the superficial fascia, transversalis fascia, and extraperitoneal fascia, while in the prone position, the focus shifts to the thoracolumbar fascia and the erector spinae complex. This technique aims to restore mobility and reduce restrictions within the fascial system.
Frequency: Each patient will recieve a single session at their most painful day from this intervention.
Kinesio Taping (KT) Intervention
Description:
Participants will receive a standardized 3-tape sensory modulation technique using Kinesiotape, applied to the abdomen and sacrum to target fascial tension and visceral pain in primary dysmenorrhea.
Procedure:
Abdominal Application (Two Tapes, 0% Stretch):
Horizontal Tape: Placed between the iliac crests (lower abdomen) to reduce fascial tension.
Vertical Tape: Applied from the navel to the pubic symphysis to modulate visceral pain signaling.
Sacral Application (One Tape, 15-25% Stretch):
Horizontal Tape: Anchored across the S2-S4 vertebrae (at PSIS level) to activate the pain-gating mechanism via cutaneous-visceral reflexes.
Frequency/Duration:
Each participant will receive a single session at their most painful day from this intervention
Time frame: Before the interventions, after 8 hours from the interventions, & 3-5 weeks post-intervention (first menstrual cycle after interventions)
It is a pain assessment tool featuring a 10-cm line marked "No pain" (0 cm) and "Worst pain imaginable" (10 cm). Patients indicate their pain level by marking the line, with scores measured in cm (0-10) and categorised as mild (0-3), moderate (4-6), or severe (7-10)
Time frame: Before the interventions, after 8 hours from the interventions, & 3-5 weeks post-intervention (first menstrual cycle after interventions)
It is a quality of life scale that questions physical function, anxiety, depression, fatigue, sleep disturbance, social roles and activities, pain interference and severity under its subheadings
Contact information is provided by the study sponsor or research team.
Medipol University
Other
Comparison of Myofascial Release and Kinesiotaping Techniques in the Management of Primary Dysmenorrhea
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06912386
Dysmenorrhea, Dysmenorrhea Primary
Chengdu, Sichuan, China
View Trial DetailsNCT06761755
Anxiety Disorders, Dysmenorrhea
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07590232
Dysmenorrhea Primary, Neurologic Manifestations
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT07466342
Dysmenorrhea Primary, Mefenamic Acid
Multan, Punjab Province, Pakistan
View Trial Details